Ivermectin compared with placebo in the clinical course in Mexican patients with asymptomatic and mild COVID-19: a randomized clinical trial

BACKGROUND: Despite the development and application of vaccines against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) around the world, the scientific community is still trying to find some therapies to avoid or ameliorate the fatal evolution of the Coronavirus disease 2019 (COVID-19)...

Descripción completa

Detalles Bibliográficos
Autores principales: de la Rocha, Carmen, Cid-López, Marco A., Venegas-López, Blanca I., Gómez-Méndez, Sandra C., Sánchez-Ortiz, Adriana, Pérez-Ríos, Alma M., Llamas-Velázquez, Ricardo A., Meza-Acuña, Aidé I., Vargas-Íñiguez, Bárbara, Rosales-Galván, Daniela, Tavares-Váldez, Alejandra, Luna-Gudiño, Nizdali, Hernández-Puente, Cinthia V., Milenkovic, Jovana, Iglesias-Palomares, Cecilia, Méndez-del Villar, Miriam, Gutiérrez-Dieck, Gerardo A., Valderrábano-Roldán, Carlos G., Mercado-Cerda, Jennefer, Robles-Bojórquez, Jocelyn G., Mercado-Sesma, Arieh R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730611/
https://www.ncbi.nlm.nih.gov/pubmed/36482326
http://dx.doi.org/10.1186/s12879-022-07890-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9730611/
https://www.ncbi.nlm.nih.gov/pubmed/36482326
http://dx.doi.org/10.1186/s12879-022-07890-6

Ejemplares similares